{"id":"W2111995867","doi":"10.1016/j.jacc.2004.11.070","title":"Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers","year":2005,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":825,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Atrial fibrillation; Cardiology; Internal medicine; Myocardial infarction; Cardioversion; Angiotensin-converting enzyme; Relative risk; Randomized controlled trial; Angiotensin receptor; Angiotensin Receptor Blockers; Angiotensin II; Confidence interval; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03696245379429191,"score_gpt":0.3252225926067658,"score_spread":0.2882601388124739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}